Literature DB >> 6091137

Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products.

G P Rice, R D Schrier, M B Oldstone.   

Abstract

In this investigation, we studied the ability of human cytomegalovirus to infect peripheral blood mononuclear cells. With monoclonal antibody technology, we demonstrated that cytomegalovirus could infect human lymphocytes of T- and B-cell lineage, natural killer cells, and monocytes. Furthermore, virus expression was limited to the synthesis of immediate-early cytomegalovirus polypeptides. These peripheral blood mononuclear cells did not produce infectious virus, nor were mature virions visualized by electron microscopy. This abortive infection of mononuclear cells was most convincingly shown with stocks of cytomegalovirus that had been recently isolated from infected patients and passaged minimally in fibroblasts. This argues for an increased lymphotropic effect of some isolates of cytomegalovirus, compared to strains of virus that are extensively adapted to growth in fibroblasts. Furthermore, immunocompetent cells that were shown to be abortively infected with cytomegalovirus lost selected differentiated functions.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6091137      PMCID: PMC391874          DOI: 10.1073/pnas.81.19.6134

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Replication of herpes simplex virus and cytomegalovirus in human leukocytes.

Authors:  C R Rinaldo; B S Richter; P H Black; R Callery; L Chess; M S Hirsch
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

3.  Susceptibility of lymphoblastoid cells to infection with human cytomegalovirus.

Authors:  M J Tocci; S C St Jeor
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

4.  Cytomegalovirus replication in cells pretreated with 5-iodo-2'-deoxyuridine.

Authors:  S St Jeor; F Rapp
Journal:  J Virol       Date:  1973-06       Impact factor: 5.103

Review 5.  The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. I.

Authors:  T H Weller
Journal:  N Engl J Med       Date:  1971-07-22       Impact factor: 91.245

6.  Latent cytomegalovirus infection in blood donors.

Authors:  P Diosi; E Moldovan; N Tomescu
Journal:  Br Med J       Date:  1969-12-13

7.  Epidemiology of cytomegalovirus infection after transplantation and immunosuppression.

Authors:  M Fiala; J E Payne; T V Berne; T C Moore; W Henle; J Z Montgomerie; S N Chatterjee; L B Guze
Journal:  J Infect Dis       Date:  1975-10       Impact factor: 5.226

8.  Interaction of cytomegalovirus with leukocytes from patients with mononucleosis due to cytomegalovirus.

Authors:  C R Rinaldo; P H Black; M S Hirsch
Journal:  J Infect Dis       Date:  1977-11       Impact factor: 5.226

9.  Reduction of postperfusion cytomegalovirus-infections following the use of leukocyte depleted blood.

Authors:  D J Lang; P A Ebert; B M Rodgers; H P Boggess; R S Rixse
Journal:  Transfusion       Date:  1977 Jul-Aug       Impact factor: 3.157

10.  Pathogenesis of of cytomegalovirus infection. I. Activation of virus from bone marrow-derived lymphocytes by in vitro allogenic reaction.

Authors:  L B Olding; F C Jensen; M B Oldstone
Journal:  J Exp Med       Date:  1975-03-01       Impact factor: 14.307

View more
  139 in total

1.  Human herpesviruses in the cornea.

Authors:  S B Kaye; K Baker; R Bonshek; H Maseruka; E Grinfeld; A Tullo; D L Easty; C A Hart
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  Coding potential of laboratory and clinical strains of human cytomegalovirus.

Authors:  Eain Murphy; Dong Yu; Jane Grimwood; Jeremy Schmutz; Mark Dickson; Michael A Jarvis; Gabriele Hahn; Jay A Nelson; Richard M Myers; Thomas E Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

3.  Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts.

Authors:  T C Wu; R H Hruban; R F Ambinder; M Pizzorno; D E Cameron; W A Baumgartner; B A Reitz; G S Hayward; G M Hutchins
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

4.  Experimental human cytomegalovirus latency in CD14+ monocytes.

Authors:  Danna Hargett; Thomas E Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

Review 5.  The role of cytomegalovirus in angiogenesis.

Authors:  Patrizia Caposio; Susan L Orloff; Daniel N Streblow
Journal:  Virus Res       Date:  2010-10-01       Impact factor: 3.303

6.  The Anatomy of a Career in Science.

Authors:  Michael B A Oldstone
Journal:  DNA Cell Biol       Date:  2016-02-02       Impact factor: 3.311

7.  Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infections.

Authors:  J A Mercer; C A Wiley; D H Spector
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

8.  Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus.

Authors:  P L Schwimmbeck; T Dyrberg; D B Drachman; M B Oldstone
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

9.  Human cytomegalovirus inhibits differentiation of monocytes into dendritic cells with the consequence of depressed immunological functions.

Authors:  Sara Gredmark; Cecilia Söderberg-Nauclér
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection.

Authors:  C Söderberg; S Larsson; S Bergstedt-Lindqvist; E Möller
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.